But study's observational design and lack of a control group limit the findings' impact ...

Psychiatrist Daniel Montville explains when medication can help reduce heavy drinking, what progress looks like and where the ...

The naltrexone dose for opioid use disorder (OUD) typically starts at 25 milligrams (mg), which may be increased to 50 mg. The recommended dose of this drug for alcohol use disorder (AUD) is 50 mg.

Share on Pinterest Naltrexone (referred to as the “Ozempic of alcohol”) is a drug that can help reduce alcohol and opioid cravings for people living with substance misuse disorder. vitapix/Getty ...

Common side effects of naltrexone include nausea, headache, anxiety, and insomnia. But these are usually temporary. Less common but serious side effects of naltrexone include liver problems, ...

Naltrexone is a generic prescription drug used to treat certain substance use disorders. Naltrexone oral tablet does not come in any brand-name versions. This drug can cause mild to serious side ...

Please provide your email address to receive an email when new articles are posted on . Adults with alcohol use disorder who were given either form of naltrexone had reduced heavy drinking days. Both ...

Naloxone (Narcan), naltrexone (Trexan; ReVia), and Vivitrol (long-acting injectable naltrexone) changed addiction medicine into a profession with FDA-approved treatments for opioid overdose reversal, ...

The global naltrexone market is experiencing exponential growth driven by rising incidences of autoimmune diseases. The global naltrexone market is witnessing substantial growth, driven by several key ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...

St. Louis, MO, May 03, 2024 (GLOBE NEWSWIRE) -- Dr. Leonard Weinstock, a leading gastroenterologist, delves into the promising realm of low-dose naltrexone (LDN) in his recent byline article. Dr.

Extended-release naltrexone, a sustained-release monthly injectable formulation of the full mu-opioid receptor antagonist, is effective for the prevention of relapse to opioid dependence. Data ...